Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-005725
Filing Date
2025-08-12
Accepted
2025-08-12 19:22:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3220
  Complete submission text file 0001950047-25-005725.txt   4600
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Subject) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35565 | Film No.: 251208482
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
SALEKI-GERHARDT AZITA (Reporting) CIK: 0001563545 (see all company filings)